Recruiting NA Pulmonary Tuberculosis

New treatment option for Pulmonary Tuberculosis

Official title Rehabilitation of People With Post-tuberculosis Lung Disease

ClinicalTrials.gov ID: NCT06127641

What this study is testing

What it's testing
Tuberculosis (TB) can leave numerous sequelae, where survivors experience a transition from an acute illness to living with a multifaceted chronic illness. Post-TB lung disease (PD-PTB) encompasses lung diseases and pathologies that occur after one or more episodes of TB, which can affect the patient's lung health and cause disabling symptoms that strongly affect their long-term health.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Patients with post-tuberculosis lung disease, clinically stable and able to perform \>80% of training sessions.

You likely can't join if

  • Presence of comorbidities not related to PD-PTB.
  • Patients with inability to perform TGlittre.
  • Patients who have cognitive changes that impair their inclusion in the study.
  • Treatment abandonment during the application of the PR protocol.
  • Uncontrolled hypertension or use of psychotropic medications.
  • Any significant limitations due to osteoarthropathy.
See the full eligibility criteria
Who can join
  • Patients with post-tuberculosis lung disease, clinically stable and able to perform \>80% of training sessions.
What rules you out
  • Presence of comorbidities not related to PD-PTB.
  • Patients with inability to perform TGlittre.
  • Patients who have cognitive changes that impair their inclusion in the study.
  • Treatment abandonment during the application of the PR protocol.
  • Uncontrolled hypertension or use of psychotropic medications.
  • Any significant limitations due to osteoarthropathy.
  • Having had any orthopedic surgery in the previous year.

The study team makes the final eligibility decision.

Where it's taking place

  • Rio de Janeiro, Brazil

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Rio de Janeiro, Brazil. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.